We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

CTC Protein Expression Uses Microfluidic Western Blotting

By LabMedica International staff writers
Posted on 06 Apr 2017
Print article
Image: Microfluidic rare-cell workflow for multiplexed western blotting of single patient-derived CTCs (Photo courtesy of University of California – Berkeley).
Image: Microfluidic rare-cell workflow for multiplexed western blotting of single patient-derived CTCs (Photo courtesy of University of California – Berkeley).
Circulating tumor cells (CTCs) are rare tumor cells found in the circulatory system of certain cancer patients and the clinical and functional significance of CTCs is still under investigation.

Circulating tumor cells have been isolated from the blood of breast cancer patients and, then microscale physics has been used to design a precision test for protein biomarkers, which are indicators of cancer.

Scientists at the University of California – Berkeley recruited 12 patients with advanced breast cancer and blood was drawn and processed with in five hours after collection. White blood cells were prepared by lysing the red blood cells. Single-cell resolution western blots (scWB) were used to measure a panel of proteins in single CTCs isolated from patients with primary estrogen receptor-positive (ER+) breast cancer.

A commercially available microfluidic tool was used for label-free isolation of circulating cancer cells in both the cell line spiking and cancer patient blood experiments. Flow cytometry analysis was performed and cells were analyzed on a Guava flow cytometer.

The scientists found that the precision handling and analysis revealed a capacity to assay sparingly available patient-derived CTCs, a biophysical CTC phenotype more lysis-resistant than breast cancer cell lines. A capacity to report protein expression was demonstrated on a per CTC basis and two statistically distinct glyceraldehyde 3-phosphate dehydrogenase (GAPDH) subpopulations within the patient-derived CTCs. By sorting and probing the protein targets, the test is more selective than existing pathology tools. Enhanced selectivity will be crucial in detecting subtle chemical modifications to biomarkers that can be important but difficult to measure.

Amy E. Herr, PhD, a professor and senior author of the study said, “Microfluidic design was key in this study. We were able to integrate features needed for each measurement stage into one process. Systems integration allowed us to do every single measurement step very, very quickly while the biomarkers are still concentrated. If not performed exceptionally fast, the cell's proteins diffuse away and become undetectable.” The study was published on March 23, 2017, in the journal Nature Communications.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.